Bangalore (Karnataka) [India], August 18 (ANI/NewsVoir): 4baseCare, a precision oncology company in India, launched their product - TARGT Indiegene, India's largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1,500 cancer pati
Washington [US], August 1 (ANI): According to a new study led by Vanderbilt University Medical Center, a biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients.
North Carolina [US], July 31 (ANI): A new study shows that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.
Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.
Washington [US], July 27 (ANI): A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study led by Vanderbilt University Medical Center.
Tennessee [US], July 24 (ANI): During a new study, researchers from St. Jude Children's Research Hospital demonstrated that in order to capitalize on the lifesaving potential of precision medicine, comprehensive genomic sequencing of all paediatric cancer patients is feasible and essential.
New Delhi [India], July 19 (ANI): The Ministry of Science and Technology on Monday informed that a group of scientists have developed a novel and cheap three dimensional (3D) Robotic motion phantom that can reproduce human lung motion which will help to deliver focussed radiation in cance
Stockholm [Sweden], July 6 (ANI): Researchers at Uppsala University in Sweden have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour.
Washington [US], July 3 (ANI): An international team of researchers with a recent survey found that nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.
Washington [US], July 1 (ANI): According to a new study, nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.
Pune (Maharashtra) [India], June 15 (ANI/PNN): Cancer patients in India now have access to CURIA, a first-of-its-kind app developed by Swiss company OncoCoin AG, the most decentralized and equitable ecosystem of cancer information. CURIA, with a global community of over 150,000, empowers pat
Washington [US], June 15 (ANI): Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, suggested a new study led by cancer researchers at UT Southwestern Medical Center.